ASML vs DHR: Which Is the Better Buy?
Side-by-side comparison of ASML Holding N.V. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
ASML Holding N.V. · Technology
$1,929.68
+45.0% upside to fair value
Grade B
High Quality
VS
Danaher Corporation · Healthcare
$177.17
+8.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
ASML has more upside to fair value
(+45.0%).
DHR trades at a lower forward P/E
(34.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ASML |
DHR |
| Current Price |
$1,929.68 |
$177.17 |
| Fair Value Estimate |
$2,798.04 |
$192.90 |
| Upside to Fair Value |
+45.0%
|
+8.9%
|
| Market Cap |
$743.7B |
$125.4B |
| Forward P/E |
64.0x
|
34.1x
|
| EV / EBITDA |
48.6x
|
20.8x
|
| Price / Sales |
19.0x
|
5.1x
|
| Price / FCF |
71.3x
|
23.7x
|
| Revenue Growth YoY |
+13.2%
|
+3.7%
|
| Gross Margin |
52.6%
|
60.7%
|
| Operating Margin |
34.8%
|
21.0%
|
| Return on Equity |
52.0%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
1.4%
|
4.22%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
ASML Holding N.V. is a leading technology company specializing in advanced lithography systems critical to semiconductor manufacturing, with a dominant market position in EUV lithography capturing near 100% share and over 90% in advanced DUV. The company benefits from a durable competitive moat supported by multi-year technology roadmaps, a deep installed base, and a disciplined management team l…
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
Accumulation Zones
| Metric |
ASML |
DHR |
| Zone Low |
$2,098.53 |
$144.68 |
| Zone High |
$2,378.33 |
$163.97 |
| In Buy Zone? |
Yes
|
No
|